Get Started

ANEB

PINK Anebulo Pharmaceuticals, Inc.
Nov 4, 2026 · 1:59 PM ET DELAYED Market Open

$0.2600 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2600, and at the day’s high of $0.2600

YTD change
-74.26%
vs 20-day SMA
+0.14%
vs 200-day SMA
-48.57%

Price ranges

Previous day
$0.2600 $0.2600
open $0.2600 close $0.2600
+$0.0000 (+0.00%)
Today
$0.2600 $0.2600
open $0.2600 now $0.2600
+$0.0000 (+0.00%)
Past week
$0.2418 $0.2750
from $0.2600 now $0.2600
+$0.0000 (+0.00%)
Past month
$0.0004 $0.3200
from $0.3200 now $0.2600
-$0.0600 (-18.75%)
This year
$0.0004 $1.2300
from $1.0100 now $0.2600
-$0.7500 (-74.26%)

Price & Performance

-0.20 (-43.48%) / 6M

$-0.0412$0.1597$0.3607$0.5616May 4Jul 31Nov 3

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 97.2% away from all-time highs of $9.3300
  • ANEB is down 74% since the beginning of the year
  • ANEB is down 90% over the past 12 months
  • ANEB is down 19% over the past 1 month
  • 2% of all ANEB investors are betting against ANEB

ANEB reads n/a: price sits above one of the two key moving averages, the 12-month move is -89.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0487
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.6M
Beta -2.73

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$9.0M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $10.6M

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $973.36 +1.26%
IQV IQVIA Holdings Inc $262.59 +1.61%
CRL Charles River Laboratories International, Inc. $351.87 +3.94%
ICLR ICON Plc $203.77 -0.67%
IT Gartner, Inc. $204.22 -13.19%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.